Genetics-testing company 23andMe has warned there is “substantial doubt” over its continued survival unless it raises new ...

DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...

The therapeutic programs of 23andMe include an antibody that restores the ability of the immune system to kill cancer cells.

The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.

Adjusted EBITDA is a key measure used by 23andMe's management and the board of directors to understand and evaluate operating ...

Prior to that, 23andMe’s independent directors—Roelof Botha, Patrick Chung, Sandra Hernández, Neal Mohan, Valerie Montgomery ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and ...

Bay Area genetic testing company 23andMe announced Monday that it plans to lay off 40% of its workforce as part of a broader restructuring effort aimed at cutting costs and refocusing the company on ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

actionable proposal that is in the best interests of the non-affiliated shareholders,” the directors wrote in their ...

A poster campaign is creating awareness commemorating Edmonton-area soldiers who never came home. Joe MacDonald, the founder ...